Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2009

01-10-2009 | Epidemiology

Alcohol intake over the life course and mammographic density

Authors: Julie D. Flom, Jennifer S. Ferris, Parisa Tehranifar, Mary Beth Terry

Published in: Breast Cancer Research and Treatment | Issue 3/2009

Login to get access

Abstract

Alcohol intake is one of the few modifiable risk factors for breast cancer. Current alcohol intake has been associated with mammographic density, a strong intermediate marker of breast cancer risk, though few studies have examined the effect of both current and average lifetime alcohol intake. We interviewed 262 participants from a New York birth cohort (born 1959–1963) and obtained mammograms from 163 (71.5% of participants with a mammogram). We collected information on alcohol intake by beverage type separately for each decade of life. We used multivariable linear models to assess the associations between current and average lifetime alcohol intake and mammographic density using a quantitative measure of density from digitized images. Overall, current alcohol intake was more strongly associated with mammographic density than average lifetime alcohol intake; compared with nondrinkers, those with current intake of seven or more servings per week had on average 12.3% (95% CI: 4.3, 20.4) higher density, adjusted for average lifetime alcohol intake, age, and body mass index. We observed a consistent inverse association for red wine intake and mammographic density, suggesting that the positive association between mammographic density and overall alcohol intake was driven by other types of alcoholic beverages. Our findings support an association between current alcohol intake and increased mammographic density independent of the effect of average lifetime alcohol intake. If replicated, our study suggests that reducing current alcohol consumption, particularly beer and white wine intake, may be a means of reducing mammographic density regardless of intake earlier in life.
Literature
1.
go back to reference World Cancer Research Fund/American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. AICR, Washington DC World Cancer Research Fund/American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. AICR, Washington DC
3.
go back to reference Hamajima N et al (2002) Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58, 515 women with breast cancer and 95, 067 women without the disease. Br J Cancer 87(11):1234–1245. doi:10.1038/sj.bjc.6600596 PubMedCrossRef Hamajima N et al (2002) Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58, 515 women with breast cancer and 95, 067 women without the disease. Br J Cancer 87(11):1234–1245. doi:10.​1038/​sj.​bjc.​6600596 PubMedCrossRef
4.
go back to reference Hiatt RA (1990) Alcohol consumption and breast cancer. Med Oncol Tumor Pharmacother 7(2–3):143–151PubMed Hiatt RA (1990) Alcohol consumption and breast cancer. Med Oncol Tumor Pharmacother 7(2–3):143–151PubMed
7.
go back to reference Martin LJ, Boyd NF (2008) Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 10(1):201. doi:10.1186/bcr1831 PubMedCrossRef Martin LJ, Boyd NF (2008) Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence. Breast Cancer Res 10(1):201. doi:10.​1186/​bcr1831 PubMedCrossRef
9.
go back to reference Boyd NF et al (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7(12):1133–1144PubMed Boyd NF et al (1998) Mammographic densities and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7(12):1133–1144PubMed
12.
go back to reference Boyd NF et al (1995) Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol Biomarkers Prev 4(7):727–733PubMed Boyd NF et al (1995) Plasma lipids, lipoproteins, and mammographic densities. Cancer Epidemiol Biomarkers Prev 4(7):727–733PubMed
13.
14.
17.
go back to reference Vachon CM et al (2000) Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev 9(2):151–160PubMed Vachon CM et al (2000) Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev 9(2):151–160PubMed
19.
go back to reference Gapstur SM et al (2003) Associations of breast cancer risk factors with breast density in Hispanic women. Cancer Epidemiol Biomarkers Prev 12(10):1074–1080PubMed Gapstur SM et al (2003) Associations of breast cancer risk factors with breast density in Hispanic women. Cancer Epidemiol Biomarkers Prev 12(10):1074–1080PubMed
22.
go back to reference Brisson J et al (1989) Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 130(1):14–24PubMed Brisson J et al (1989) Diet, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 130(1):14–24PubMed
23.
go back to reference Broman SH (1984) The collaborative perinatal project: an overview. In: Mednick SA, Harway M, Finello KM (eds) Hanbook of longitudinal research. Praeger, New York, pp 166–179 Broman SH (1984) The collaborative perinatal project: an overview. In: Mednick SA, Harway M, Finello KM (eds) Hanbook of longitudinal research. Praeger, New York, pp 166–179
25.
go back to reference Harvey EB et al (1987) Alcohol consumption and breast cancer. J Natl Cancer Inst 78(4):657–661PubMed Harvey EB et al (1987) Alcohol consumption and breast cancer. J Natl Cancer Inst 78(4):657–661PubMed
29.
go back to reference Blot WJ (1992) Alcohol and cancer. Cancer Res 52(7 (Suppl)):2119s–2123sPubMed Blot WJ (1992) Alcohol and cancer. Cancer Res 52(7 (Suppl)):2119s–2123sPubMed
31.
go back to reference Byrne C et al (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3 and Mammographic density. Cancer Res 60:3744–3748PubMed Byrne C et al (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3 and Mammographic density. Cancer Res 60:3744–3748PubMed
36.
go back to reference National Center for Health Statistics Health, United States (2007) With Chartbook on Trends in the Health of Americans. Hyattsville, MD National Center for Health Statistics Health, United States (2007) With Chartbook on Trends in the Health of Americans. Hyattsville, MD
37.
go back to reference US Department of Health and Human Services and US Department of Agriculture (2005) Dietary guidelines for Americans, 6th edn. US Government Printing Office, Washington DC US Department of Health and Human Services and US Department of Agriculture (2005) Dietary guidelines for Americans, 6th edn. US Government Printing Office, Washington DC
39.
go back to reference Cuzick J et al (2004) Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96(8):621–628PubMedCrossRef Cuzick J et al (2004) Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 96(8):621–628PubMedCrossRef
Metadata
Title
Alcohol intake over the life course and mammographic density
Authors
Julie D. Flom
Jennifer S. Ferris
Parisa Tehranifar
Mary Beth Terry
Publication date
01-10-2009
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2009
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0302-0

Other articles of this Issue 3/2009

Breast Cancer Research and Treatment 3/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine